Skip to main content
. 2024 Aug 26;16(17):2970. doi: 10.3390/cancers16172970

Figure 5.

Figure 5

Effect of PLGA-PEI-si-m/hVDAC1-B treatment on the expression of CSC-related markers. (A,B) Representative lung sections IHC stained with specific antibodies against SOX2 (A) and ALDHA1 (B), showing enlarged areas from tumor-free and tumor tissues. (C,D) Representative IHC staining of stem cell markers CD44 and CD1133 in PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice (C) and their quantified staining intensity (D). Results reflect the mean ± SEM (n = 3), ** p ≤ 0.01, *** p ≤ 0.001.